MX2021006266A - Puntajes de riesgo genetico de ascendencia especifica. - Google Patents

Puntajes de riesgo genetico de ascendencia especifica.

Info

Publication number
MX2021006266A
MX2021006266A MX2021006266A MX2021006266A MX2021006266A MX 2021006266 A MX2021006266 A MX 2021006266A MX 2021006266 A MX2021006266 A MX 2021006266A MX 2021006266 A MX2021006266 A MX 2021006266A MX 2021006266 A MX2021006266 A MX 2021006266A
Authority
MX
Mexico
Prior art keywords
ancestry
risk scores
genetic risk
individual
specific genetic
Prior art date
Application number
MX2021006266A
Other languages
English (en)
Inventor
Mun Yew Wong
Jia Yi Har
Pauline C Ng
Chun Meng Ong
Robert Keams Valenzuela
Vishweshwaran Sridhar
Original Assignee
Asia Genomics Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asia Genomics Pte Ltd filed Critical Asia Genomics Pte Ltd
Publication of MX2021006266A publication Critical patent/MX2021006266A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/15—Correlation function computation including computation of convolution operations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)

Abstract

En la presente, se describen métodos y sistemas para calcular puntajes de riesgo genético (GRS) que representan la probabilidad de que un individuo desarrolle un rasgo específico basado en la ascendencia del mismo. También se proporcionan métodos y sistemas para dar una recomendación al individuo, para modificar un comportamiento relacionado con un rasgo específico, basada en el GRS del individuo para dicho rasgo.
MX2021006266A 2018-11-28 2019-10-31 Puntajes de riesgo genetico de ascendencia especifica. MX2021006266A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862772565P 2018-11-28 2018-11-28
US16/216,940 US10468141B1 (en) 2018-11-28 2018-12-11 Ancestry-specific genetic risk scores
PCT/IB2019/001179 WO2020109858A1 (en) 2018-11-28 2019-10-31 Ancestry-specific genetic risk scores

Publications (1)

Publication Number Publication Date
MX2021006266A true MX2021006266A (es) 2021-09-10

Family

ID=68391819

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006266A MX2021006266A (es) 2018-11-28 2019-10-31 Puntajes de riesgo genetico de ascendencia especifica.

Country Status (13)

Country Link
US (1) US10468141B1 (es)
EP (1) EP3888092A1 (es)
JP (1) JP2022511765A (es)
KR (1) KR20210100650A (es)
CN (1) CN113614833B (es)
AU (1) AU2019387560A1 (es)
BR (1) BR112021010323A2 (es)
CA (1) CA3121118A1 (es)
GB (1) GB2595373A (es)
MX (1) MX2021006266A (es)
SG (1) SG11202105645PA (es)
TW (1) TWI816927B (es)
WO (1) WO2020109858A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080228700A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Attribute Combination Discovery
US8463554B2 (en) 2008-12-31 2013-06-11 23Andme, Inc. Finding relatives in a database
US10777302B2 (en) * 2012-06-04 2020-09-15 23Andme, Inc. Identifying variants of interest by imputation
CN111394441B (zh) * 2020-04-30 2022-11-15 北京和合医学诊断技术股份有限公司 用于维生素a相关基因扩增的引物组、试剂盒及方法
US20220101945A1 (en) * 2020-09-28 2022-03-31 Ut-Battelle, Llc Specific structural variants discovered with non-mendelian inheritance
CN113201593B (zh) * 2021-05-25 2024-01-23 广州盛世中豪运动科技有限公司 用于检测actn3基因型的引物探针组合产品
CN113337597B (zh) * 2021-07-02 2022-10-04 厦门市妇幼保健院（厦门市计划生育服务中心） 用于孕期维生素a缺乏风险评估检测试剂盒与应用方法
TWI795139B (zh) * 2021-12-23 2023-03-01 國立陽明交通大學 自動化致病突變點位的分類系統及其分類方法
CN115206420B (zh) * 2022-06-27 2023-05-23 南方医科大学南方医院 一种精神分裂症异常基因-代谢调控网络的构建方法及应用
CN117711488A (zh) * 2023-11-29 2024-03-15 东莞博奥木华基因科技有限公司 一种基于长读长测序的基因单倍型检测方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3997300A (en) * 1999-02-22 2000-09-14 Variagenics, Inc. Gene sequence variations with utility in determining the treatment of disease
FI116468B (fi) * 2002-04-04 2005-11-30 Licentia Oy Geenikartoitusmenetelmä genotyyppi- ja fenotyyppidatasta sekä muistiväline ja tietokonejärjestelmä menetelmän suorittamiseksi
US7645575B2 (en) * 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
CA2632230C (en) * 2005-11-26 2019-05-07 Gene Security Network, Inc. System and method for cleaning noisy genetic data and using genetic, phentoypic and clinical data to make predictions
EP2115172A1 (en) 2007-02-21 2009-11-11 Decode Genetics EHF Genetic susceptibility variants associated with cardiovascular disease
CA2700975A1 (en) * 2007-09-26 2009-04-02 Navigenics, Inc. Methods and systems for genomic analysis using ancestral data
US9367800B1 (en) 2012-11-08 2016-06-14 23Andme, Inc. Ancestry painting with local ancestry inference
US20100036720A1 (en) * 2008-04-11 2010-02-11 Microsoft Corporation Ubiquitous intent-based customer incentive scheme
US8428886B2 (en) 2008-08-26 2013-04-23 23Andme, Inc. Genotype calling
US9218451B2 (en) 2008-08-26 2015-12-22 23Andme, Inc. Processing data from genotyping chips
EP2532199B1 (en) * 2010-02-04 2019-09-04 TomTom Traffic B.V. Location-determining system and method
WO2013067001A1 (en) * 2011-10-31 2013-05-10 The Scripps Research Institute Systems and methods for genomic annotation and distributed variant interpretation
US9213947B1 (en) 2012-11-08 2015-12-15 23Andme, Inc. Scalable pipeline for local ancestry inference
US9910962B1 (en) 2013-01-22 2018-03-06 Basehealth, Inc. Genetic and environmental risk engine and methods thereof
KR20180086264A (ko) * 2015-12-23 2018-07-30 테크놀로지안 투트키무스케스쿠스 브이티티 오와이 세포로부터 인디케이터 신호를 얻는 방법
AU2017292854B2 (en) * 2016-07-06 2023-08-17 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids

Also Published As

Publication number Publication date
US10468141B1 (en) 2019-11-05
GB2595373A (en) 2021-11-24
EP3888092A1 (en) 2021-10-06
KR20210100650A (ko) 2021-08-17
JP2022511765A (ja) 2022-02-01
CN113614833A (zh) 2021-11-05
WO2020109858A1 (en) 2020-06-04
BR112021010323A2 (pt) 2021-08-24
GB202109153D0 (en) 2021-08-11
AU2019387560A1 (en) 2021-07-15
CN113614833B (zh) 2024-04-23
SG11202105645PA (en) 2021-06-29
CA3121118A1 (en) 2020-06-04
TW202036583A (zh) 2020-10-01
TWI816927B (zh) 2023-10-01

Similar Documents

Publication Publication Date Title
MX2021006266A (es) Puntajes de riesgo genetico de ascendencia especifica.
WO2018203147A3 (en) MULTILINGUAL SEMANTIC ANALYZER BASED ON TRANSFERRED LEARNING
PH12019502200A1 (en) Method, apparatus, and system for blockchain consensus
PH12019501153A1 (en) System and method for implementing native contract on blockchain
MX2018004400A (es) Metodos y sistemas para mejorar la condicion dermica.
MX2018015256A (es) Metodos para identificar cruzas para usar en reproduccion de plantas.
WO2018020389A3 (en) Blockchain implemented method and system
MX2018008104A (es) Identificacion de entidades utilizando un modelo de aprendizaje profundo.
MX2020014325A (es) Sistemas y métodos para determinar un evento malicioso potencial.
SG10201708490WA (en) System and method for processing a loan application
PH12019501369A1 (en) User credit assessment
MX2021004532A (es) Metodos y composiciones para terapia con celulas oculares.
MX2020002093A (es) Sistema y metodo de resolucion de entidad genealogica.
SG11201810348XA (en) Program, information processing apparatus and information processing method
PH12015000292A1 (en) Hybrid adaptive authentication scoring system
WO2018140515A8 (en) SYSTEM AND METHODS FOR DETERMINING EVENTS OF INTEREST IN A MULTI-PLAYER ONLINE GAME
FI20185922A1 (fi) Tekniset piirustukset ja digitaaliset kaksoset
MX2021013913A (es) Composiciones y metodos para el tratamiento de enfermedades mediadas por atpasa.
MX2019001946A (es) Marcador para celulas madre neurales.
SG10201702945VA (en) System and Method for Administering a User Account
PH12019500717A1 (en) Method, server and system for providing group buying service for insurance product
MX2020002462A (es) Estratificacion de genotipo en tratamiento y prevencion de diabetes.
MX353711B (es) Sistemas, métodos y dispositivos de comunicaciones electrónicas que tienen pérdida incrementada de información.
GB2584939B (en) Information processing system, and platform
MX2021000543A (es) Sistema y metodo para la resolucion de entidades genealogicas.